Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump

被引:104
作者
Liu, J
Takiff, HE
Nikaido, H
机构
[1] UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA
[2] INST VENEZOLANO INVEST CIENT, CARACAS, VENEZUELA
关键词
D O I
10.1128/jb.178.13.3791-3795.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The lfrA gene cloned from chromosomal DNA of quinolone-resistant Mycobacterium smegmatis mc(2)-552 conferred low-level resistance to fluoroquinolones when present on multicopy plasmids. Sequence analysis suggested that IfrA encodes a membrane efflux pump of the major facilitator family (H. E. Takiff M. Cimino, M. C. Musso, T. Weisbrod, R. Martinet, M. B. Delgado, L. Salazar, B. R. Bloom, and W. R. Jacbos, Jr., Proc. Natl. Acad, Sci, USA 93:362-366, 1996). In this work, we studied the role of LfrA in the accumulation of fluoroquinolones by M. smegmatis. The steady-state accumulation level of a hydrophilic quinolone, norfloxacin, by M. smegmatis harboring a plasmid carrying the IfrA gene was about 50% of that by the parent strain but was increased to the same level as that of the parent strain by addition of a proton conductor, carbonyl cyanide m-chorophenylhydrazone. Norfloxacin efflux mediated by LfrA was competed for strongly by ciprofloxacin but not by nalidixic acid, Furthermore, we showed that portions of norfloxacin accumulated by starved cells were pumped out upon reenergization of the cells, and the rates of this efflux showed evidence of saturation at higher intracellular concentrations of the drug. These results suggest that the LfrA polypeptide catalyzes the active efflux of several quinolones.
引用
收藏
页码:3791 / 3795
页数:5
相关论文
共 36 条
[1]   THE ENVELOPE OF MYCOBACTERIA [J].
BRENNAN, PJ ;
NIKAIDO, H .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :29-63
[2]   IMPERMEABILITY TO QUINOLONES IN GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA [J].
BRYAN, LE ;
BEDARD, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (04) :232-239
[3]   SELECTION OF A GYRA MUTANT OF MYCOBACTERIUM-TUBERCULOSIS RESISTANT TO FLUOROQUINOLONES DURING TREATMENT WITH OFLOXACIN [J].
CAMBAU, E ;
SOUGAKOFF, W ;
BESSON, M ;
TRUFFOTPERNOT, C ;
GROSSET, J ;
JARLIER, V .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :479-483
[4]   CHARACTERIZATION OF MECHANISMS OF QUINOLONE RESISTANCE IN PSEUDOMONAS-AERUGINOSA STRAINS ISOLATED INVITRO AND INVIVO DURING EXPERIMENTAL ENDOCARDITIS [J].
CHAMBERLAND, S ;
BAYER, AS ;
SCHOLLAARDT, T ;
WONG, SA ;
BRYAN, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :624-634
[5]  
COHEN SP, 1988, ANTIMICROB AGENTS CH, V32, P1182
[6]   THE EMERGENCE OF DRUG-RESISTANT TUBERCULOSIS IN NEW-YORK-CITY [J].
FRIEDEN, TR ;
STERLING, T ;
PABLOSMENDEZ, A ;
KILBURN, JO ;
CAUTHEN, GM ;
DOOLEY, SW .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :521-526
[7]   TREATMENT OF 171 PATIENTS WITH PULMONARY TUBERCULOSIS RESISTANT TO ISONIAZID AND RIFAMPIN [J].
GOBLE, M ;
ISEMAN, MD ;
MADSEN, LA ;
WAITE, D ;
ACKERSON, L ;
HORSBURGH, CR .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :527-532
[8]  
GRINIUS LL, 1994, J BIOL CHEM, V269, P29998
[9]   OUTER-MEMBRANE CHANGES IN QUINOLONE RESISTANT PSEUDOMONAS-AERUGINOSA [J].
HASHMI, ZS ;
SMITH, JMB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (03) :465-470
[10]   GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF NORFLOXACIN RESISTANCE IN ESCHERICHIA-COLI [J].
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
TUNG, C ;
MCHUGH, GL ;
SWARTZ, MN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :639-644